tiprankstipranks
Shanghai Kindly Medical Instruments Co., Ltd. Class H (HK:1501)
:1501
Hong Kong Market

Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) AI Stock Analysis

Compare
2 Followers

Top Page

HK:1501

Shanghai Kindly Medical Instruments Co., Ltd. Class H

(1501)

Select Model
Select Model
Select Model
Rating:73Outperform
Price Target:
HK$35.00
▲(19.45% Upside)
Action:ReiteratedDate:10/28/25
The overall stock score of 73 for Shanghai Kindly Medical Instruments is primarily driven by strong financial performance (score: 81, weight: 0.5), reflecting robust profitability and a stable balance sheet. Technical analysis (score: 65, weight: 0.3) shows a bullish trend but weakening momentum, while valuation (score: 60, weight: 0.2) indicates the stock is fairly valued with limited upside. Financial health remains the key strength, though investors should monitor cash flow conversion and market momentum.
Positive Factors
Revenue Growth
The company has shown consistent revenue growth, with a 13.15% increase from 2023 to 2024, indicating a strong market position and demand for its products.
Negative Factors
Cash Flow Challenges
Challenges in cash generation from operations could impact liquidity and limit the ability to fund new investments or manage debt.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The company has shown consistent revenue growth, with a 13.15% increase from 2023 to 2024, indicating a strong market position and demand for its products.
Read all positive factors

Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Kindly Medical Instruments Co., Ltd. Class H Business Overview & Revenue Model

Company Description
Shanghai Kindly Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers int...
How the Company Makes Money
The company generates revenue through the sale of its medical instruments and devices, which are distributed to healthcare facilities both domestically and internationally. Key revenue streams include direct sales of surgical instruments, medical ...

Shanghai Kindly Medical Instruments Co., Ltd. Class H Financial Statement Overview

Summary
Shanghai Kindly Medical Instruments exhibits strong financial health with an Income Statement score of 85, driven by high profitability margins and 13.1% revenue growth. The Balance Sheet score of 78 reflects a solid capital structure with low leverage, though debt levels need monitoring. Cash Flow scores at 70, with improved Free Cash Flow but limited cash conversion, posing potential constraints.
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue920.71M851.95M752.84M585.88M464.68M358.43M
Gross Profit561.55M537.66M438.07M332.49M275.75M234.41M
EBITDA277.22M255.43M225.88M159.99M168.81M143.23M
Net Income189.90M191.91M156.46M131.71M142.96M121.35M
Balance Sheet
Total Assets2.88B2.26B2.03B1.83B1.62B1.42B
Cash, Cash Equivalents and Short-Term Investments505.05M554.51M434.40M528.27M640.55M941.59M
Total Debt569.86M243.69M94.78M48.83M13.40M1.73M
Total Liabilities917.75M473.39M351.25M273.23M183.63M95.04M
Stockholders Equity1.88B1.77B1.65B1.51B1.40B1.31B
Cash Flow
Free Cash Flow146.08M59.80M-53.05M-62.75M-205.07M7.92M
Operating Cash Flow243.39M225.54M178.15M180.46M72.76M95.71M
Investing Cash Flow-455.54M-187.31M-283.81M-316.18M-268.08M-221.87M
Financing Cash Flow360.65M56.97M8.06M9.72M-31.07M-27.95M

Shanghai Kindly Medical Instruments Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Positive
Last Price29.30
Price Trends
50DMA
30.88
Positive
100DMA
30.63
Positive
200DMA
29.53
Positive
Market Momentum
MACD
<0.01
Negative
RSI
54.68
Neutral
STOCH
56.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1501, the sentiment is Positive. The current price of 29.3 is below the 20-day moving average (MA) of 30.27, below the 50-day MA of 30.88, and below the 200-day MA of 29.53, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.68 is Neutral, neither overbought nor oversold. The STOCH value of 56.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1501.

Shanghai Kindly Medical Instruments Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$1.52B6.783.68%7.46%21.39%-0.57%
74
Outperform
HK$5.93B3.5116.76%3.65%6.87%18.37%
73
Outperform
HK$6.61B10.0710.41%14.06%3.02%
72
Outperform
HK$27.50B14.5724.01%0.63%13.58%24.59%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
HK$630.27M-2.63-8.46%45.13%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
31.32
4.12
15.15%
HK:1358
PW Medtech Group Ltd.
1.03
0.09
9.57%
HK:0876
Kaisa Health Group Holdings Limited
0.13
0.10
362.96%
HK:3600
Modern Dental Group Limited
6.35
2.64
71.21%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
54.25
27.58
103.41%

Shanghai Kindly Medical Instruments Co., Ltd. Class H Corporate Events

Shanghai Kindly Medical Instruments Proposes Full Circulation of H Shares
Nov 12, 2025
Shanghai Kindly Medical Instruments Co., Ltd. has announced its intention to implement full circulation of its H shares. The company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the conversion of 71,786,608 domes...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 28, 2025